These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14188794)

  • 1. HYDROXYUREA. A NEW TYPE OF POTENTIAL ANTITUMOR AGENT.
    STEARNS B; LOSEE KA; BERNSTEIN J
    J Med Chem; 1963 Mar; 6():201. PubMed ID: 14188794
    [No Abstract]   [Full Text] [Related]  

  • 2. ACTIVITY OF CONGENERS OF HYDROXYUREA AGAINST ADVANCED LEUKEMIA L1210.
    ADAMSON RH
    Proc Soc Exp Biol Med; 1965 Jun; 119():456-8. PubMed ID: 14328917
    [No Abstract]   [Full Text] [Related]  

  • 3. ANTILEUKEMIC ACTIVITY OF HYDROXYUREA (NSC-32065) AND OTHER UREA DERIVATIVES.
    GOLDIN A; VENDITTI JM; MEAD JA; GLYNN JP
    Cancer Chemother Rep; 1964 Aug; 40():57-74. PubMed ID: 14206921
    [No Abstract]   [Full Text] [Related]  

  • 4. HYDROXYMETHYLGLYOXAL BISGUANYLHYDRAZONE.
    LOO TL; DION RL; DAVIDSON JD; ADAMSON RH
    J Med Chem; 1963 Nov; 6():819-20. PubMed ID: 14184964
    [No Abstract]   [Full Text] [Related]  

  • 5. THE SYNTHESIS OF ANTINEOPLASTIC AGENTS. XXXII. N-NITROSOUREAS. I.
    JOHNSTON TP; MCCALEB GS; MONTGOMERY JA
    J Med Chem; 1963 Nov; 6():669-81. PubMed ID: 14184923
    [No Abstract]   [Full Text] [Related]  

  • 6. SYNTHESIS AND ANTITUMOR ACTIVITY OF 2-AMINO-1-METHYLPURINE- 6-THIONE.
    NOELL CW; SMITH DW; ROBINS RK
    J Med Pharm Chem; 1962 Sep; 5():996-9. PubMed ID: 14056442
    [No Abstract]   [Full Text] [Related]  

  • 7. POTENTIATION OF THE ANTI-LEUKEMIC EFFECTS OF 2-AMINOTHIADIAZOLE BY ISONICOTINAMIDE AND DERIVATIVES.
    OETTGEN HF; PURPLE JR; COLEY VC; KRAKOFF IH; BURCHENAL JH
    Cancer Res; 1964 May; 24():689-92. PubMed ID: 14188475
    [No Abstract]   [Full Text] [Related]  

  • 8. OSSAMYCIN, A NEW CYTOTOXIC AGENT.
    SCHMITZ H; JUBINSKI SD; HOOPER IR; CROOK KE; PRICE KE; LEIN J
    J Antibiot (Tokyo); 1965 Mar; 18():82-8. PubMed ID: 14326088
    [No Abstract]   [Full Text] [Related]  

  • 9. 4-(1-CARBOXYETHYL)-1,4-OXATHIANIUM BROMIDE.
    BAHNER CT; SENTER G
    J Med Chem; 1963 Nov; 6():820. PubMed ID: 14184965
    [No Abstract]   [Full Text] [Related]  

  • 10. SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
    EVANS JS; BOSTWICK L; MENGEL GD
    Biochem Pharmacol; 1964 Jul; 13():983-8. PubMed ID: 14201140
    [No Abstract]   [Full Text] [Related]  

  • 11. SYNTHESIS OF ISOTHIOCYANATES AS POTENTIAL ANTINEOPLASTIC AGENTS.
    BURCKHALTER JH; BARIANA DS
    J Med Chem; 1963 Mar; 6():203-5. PubMed ID: 14188797
    [No Abstract]   [Full Text] [Related]  

  • 12. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS.
    BURCHENAL JH; OETTGEN HF; LYMAN M; PURPLE J
    Acta Unio Int Contra Cancrum; 1964; 20():256-9. PubMed ID: 14151900
    [No Abstract]   [Full Text] [Related]  

  • 13. STUDIES OF LEUKEMIA L1210 HOMOGRAFT IN SWISS HA-ICR MICE.
    BRADNER WT; BACHMAN S; PINDELL MH
    Cancer Chemother Rep; 1964 Jul; 39():21-39. PubMed ID: 14201273
    [No Abstract]   [Full Text] [Related]  

  • 14. EVALUATION OF ANTILEUKEMIC AGENTS EMPLOYING ADVANCED LEUKEMIA L1210 IN MICE. 8.
    VENDITTI JM; KLINE I; GOLDIN A
    Cancer Res; 1964 Jul; 24():827-79. PubMed ID: 14204394
    [No Abstract]   [Full Text] [Related]  

  • 15. Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity.
    Finch RA; Liu M; Grill SP; Rose WC; Loomis R; Vasquez KM; Cheng Y; Sartorelli AC
    Biochem Pharmacol; 2000 Apr; 59(8):983-91. PubMed ID: 10692563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHEMOTHERAPEUTIC EFFECTS ON MAMMALIAN TUMOR CELLS. I. MODIFICATION OF LEUKEMIA L1210 GROWTH KINETICS AND KARYOTYPE WITH AN ALKYLATING AGENT.
    JOHNSON RE; ZELEN M; KEMP NH
    J Natl Cancer Inst; 1965 Feb; 34():277-90. PubMed ID: 14293793
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacology of 3,5-diamino-1,24-triazole (guanazole). 1. Antitumor activity of guanazole.
    Hahn MA; Adamson RH
    J Natl Cancer Inst; 1972 Mar; 48(3):783-90. PubMed ID: 4621741
    [No Abstract]   [Full Text] [Related]  

  • 18. EVALUATION OF ANTILEUKEMIC AGENTS EMPLOYING ADVANCED LEUKEMIA L1210 IN MICE. VII.
    VENDIITI JM; SHELDON DR; GOLDIN A
    Cancer Res; 1964 Jan; 24():145-96. PubMed ID: 14106543
    [No Abstract]   [Full Text] [Related]  

  • 19. AN EXPERIMENTAL THERAPEUTIC APPROACH TO L1210 LEUKEMIA IN MICE: COMBINED CHEMOTHERAPY AND CENTRAL NERVOUS SYSTEM IRRADIATION.
    JOHNSON RE
    J Natl Cancer Inst; 1964 Jun; 32():1333-41. PubMed ID: 14191403
    [No Abstract]   [Full Text] [Related]  

  • 20. SYNTHESIS OF POSSIBLE CANCER CHEMOTHERAPEUTIC COMPOUNDS BASED ON ENZYME APPROACH. IV. AZIRIDINE DERIVATIVES.
    TSOU KC; HOEGERLE K; SU HC
    J Med Chem; 1963 Jul; 6():435-9. PubMed ID: 14184901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.